Latest Anticoagulant Stories
A Request To Centralize Xarelto Lawsuits Alleging Xarelto Users Experience Uncontrolled Bleeding Due To Taking The Blood Thinner Is Under Consideration By the U.S.
- Phase I study results presented at American Society of Hematology Annual Meeting RIDGEFIELD, Conn., Dec. 8, 2014 /PRNewswire/ -- Boehringer Ingelheim Pharmaceuticals, Inc.
The Xarelto Lawsuit Complaint Alleges That Janssen Pharmaceuticals And Bayer HealthCare Did Not Disclose The Bleeding Risks Associated With The Prescription Blood Thinner Medication.
- Retrospective analysis of more than 38,000 patients shows PRADAXA is associated with lower rates of stroke and major bleeding compared to warfarin RIDGEFIELD, Conn., Nov.
- Effects of idarucizumab on an exploratory marker of blood clotting, presented at the American Heart Association's Scientific Sessions RIDGEFIELD, Conn., Nov.
Findings presented at American Heart Association's Scientific Sessions add to growing body of data supporting safety and effectiveness of PRADAXA RIDGEFIELD, Conn., Nov.
The Firm is representing individuals in Xarelto lawsuits that allege use of the blood-thinning medication caused serious complications, including uncontrollable internal bleeding. New
Anticoagulation Coalition Electronic Health Record Task Force provides List of EHR features for the delivery of optimized anticoagulation therapy ST. PAUL, Minn., Nov.
The Firm is evaluating Xarelto lawsuits on behalf of patients who experienced uncontrollable internal bleeding, strokes, deep vein thrombosis, pulmonary embolism, or other complications allegedly
- A member of the swell-mob; a genteelly clad pickpocket. Sometimes mobsman.